Nuveen Asset Management’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $3.52M | Buy |
472,840
+48,525
| +11% | +$361K | ﹤0.01% | 2139 |
|
|
2024
Q3 | $2.46M | Buy |
424,315
+250,126
| +144% | +$1.45M | ﹤0.01% | 2319 |
|
|
2024
Q2 | $1.16M | Sell |
174,189
-69,116
| -28% | -$460K | ﹤0.01% | 2661 |
|
|
2024
Q1 | $3.18M | Buy |
243,305
+71,880
| +42% | +$938K | ﹤0.01% | 2181 |
|
|
2023
Q4 | $2.19M | Sell |
171,425
-266,168
| -61% | -$3.39M | ﹤0.01% | 2373 |
|
|
2023
Q3 | $5.74M | Sell |
437,593
-112
| -0% | -$1.47K | ﹤0.01% | 1793 |
|
|
2023
Q2 | $11.2M | Buy |
437,705
+148,732
| +51% | +$3.8M | ﹤0.01% | 1435 |
|
|
2023
Q1 | $7.28M | Buy |
288,973
+22,474
| +8% | +$566K | ﹤0.01% | 1674 |
|
|
2022
Q4 | $6.13M | Buy |
266,499
+138,865
| +109% | +$3.19M | ﹤0.01% | 1801 |
|
|
2022
Q3 | $2.82M | Sell |
127,634
-767
| -0.6% | -$16.9K | ﹤0.01% | 2209 |
|
|
2022
Q2 | $1.84M | Buy |
128,401
+18,782
| +17% | +$269K | ﹤0.01% | 2474 |
|
|
2022
Q1 | $2.16M | Buy |
109,619
+31,402
| +40% | +$618K | ﹤0.01% | 2470 |
|
|
2021
Q4 | $1.26M | Buy |
78,217
+41,689
| +114% | +$672K | ﹤0.01% | 2772 |
|
|
2021
Q3 | $1.06M | Sell |
36,528
-790
| -2% | -$22.9K | ﹤0.01% | 2972 |
|
|
2021
Q2 | $1.17M | Buy |
+37,318
| New | +$1.17M | ﹤0.01% | 2952 |
|